Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alimak Group ABOSTO:ALIG +0.16%86 ROE % is 8.96% as of Jun. 2026, which is 2% below its 10-year median of 9.11. GuruFocus rates OSTO:ALIG with a GF Score™ of 86/100 and a GF Value™ of kr113.18 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 3,005 Industrial Products companies, Alimak Group AB ranks better than 57.34% on this metric.
The historical rank and industry rank for Alimak Group AB's ROE % or its related term are showing as below:
OSTO:ALIG'
s ROE % Range Over the Past 10 Years
Min: 5.07 Med: 9.11 Max: 11.11
Current: 7.52
During the past 13 years, Alimak Group AB's highest ROE % was 11.11%. The lowest was 5.07%. And the median was 9.11%.
OSTO:ALIG's ROE % is ranked better than 57.34% of 3005
companies
in the Industrial Products industry
Industry Median: 5.88
vs OSTO:ALIG: 7.52
Alimak Group AB (OSTO:ALIG) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Alimak Group AB ROE % Related Terms
Alimak Group AB ROE % Historical Data
* Premium members only.
The historical data trend for Alimak Group AB's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Industrial Machinery subindustry, Alimak Group AB's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alimak Group AB ROE % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Alimak Group AB's ROE % distribution charts can be found below:
* The bar in red indicates where Alimak Group AB's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Alimak Group AB (OSTO:ALIG) has a ROE % of 8.96% as of Jun. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Alimak Group AB and its competitors. This is near median its historical median of 9.11. Over the past decade, Alimak Group AB's ROE % has ranged from 5.07 to 11.11. According to the industry distribution chart, Alimak Group AB ranks #1282 out of 3005 companies in the Industrial Products industry, placing it in the top 42.7%.
Is Alimak Group AB's ROE % too high?
Alimak Group AB's current ROE % of 8.96% is near median its 10-year median of 9.11. Over the past 10 years, this metric has ranged from a low of 5.07 to a high of 11.11. The Industrial Products industry median ROE % is 5.88. Alimak Group AB's value of 8.96% is 52.4% above this industry median. Based on the distribution chart, Alimak Group AB ranks #1282 out of 3005 companies in the Industrial Products industry, which is above the industry midpoint. Overall, Alimak Group AB has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alimak Group AB's ROE % compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Alimak Group AB ranks #1282 out of 3005 companies for ROE %. This puts Alimak Group AB in the upper half of its industry. The industry median ROE % is 5.88. Alimak Group AB's value of 8.96% is 52.4% above this benchmark. Historically, Alimak Group AB's own ROE % has ranged from 5.07 to 11.11 over the past decade. While the company's 10-year median is 9.11 vs. the industry median of 5.88, Alimak Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Industrial Products company?
The median ROE % among Industrial Products companies is 5.88, based on 3,005 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alimak Group AB's current ROE % of 8.96% is 52.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Alimak Group AB and its competitors. For the Industrial Products industry, the median ROE % is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alimak Group AB's current ROE % is 8.96%, which is near median its own 10-year median of 9.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alimak Group AB stock overvalued right now?
Based on GuruFocus' analysis, Alimak Group AB (OSTO:ALIG) is currently considered Modestly Overvalued. The stock's GF Value™ is kr113.18, compared to a current price of kr126.20 — trading 11.5% above its estimated fair value. The current ROE % is 8.96%, which is near median its 10-year median of 9.11 and 52.4% above the Industrial Products industry median of 5.88. Alimak Group AB's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Alimak Group AB (OSTO:ALIG), the current ROE % is 8.96% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alimak Group AB (OSTO:ALIG) Overvalued in 2026?
Based on GuruFocus' analysis, Alimak Group AB stock appears to be overvalued.
The current stock price of kr126.20 is trading 11.5% above its estimated GF Value™ of kr113.18.
GuruFocus considers Alimak Group AB to be Modestly Overvalued.
Key valuation signals for OSTO:ALIG:
ROE %: 8.96% (near median its 10-year median of 9.11)
GF Value™: kr113.18 vs. price of kr126.20 (11.5% above fair value)
Industry Position: 52.4% above the Industrial Products median (#1282 of 3005)
No single metric tells the full story. See the OSTO:ALIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alimak Group AB provides vertical access solutions. The company has five segments namely, Facade Access, Construction, Height Safety and Productivity Solutions, Industrial, and Wind. The Group operates in various countries and all operating segments are represented in the geographical regions of Europe, Asia and Australia, South and North America, and Other Markets. The company develops, manufactures, sells, and services various solutions with a focus on adding customer value through enhanced safety, higher productivity, and improved cost efficiency. The products and solutions are sold under the brands Alimak, Tractel, CoxGomyl, Manntech, Avanti, and Scanclimber.
86GF Score
Get the complete analysis for OSTO:ALIG
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ALIG has been successfully added to your 
